Diagnosis and treatment of hilar cholangiocarcinoma progress.docVIP

 PAGE \* MERGEFORMAT 13 Diagnosis and treatment of hilar cholangiocarcinoma progress Of: Ma Tengfei, Meng Bin, LU Hai, Zhu Biao, Luo Xu, Chen Zhixiang [Keywords:] Cholangiocarcinoma, hilar, diagnosis, treatment Hilar cholangiocarcinoma (hilar cholangiocarcinoma, HCC is the primary in the cystic duct and hepatic duct above the opening to the left and right hepatic duct parts of the mucosal cell carcinoma. At home and abroad for patients with hilar cholangiocarcinoma is still widely used in Bismuth Corlette points type, but still lacks a unified classification criteria. tumor stage as judged by survival rate after surgery for hilar cholangiocarcinoma is the primary reference standard is widely accepted, clinical staging of hilar operability is difficult. hilar easier to identify the clinical manifestations, in order to provide an effective basis for clinical diagnosis. The diagnosis mainly depends on imaging examination, purpose of checking whether in addition to diagnosis of hilar cholangiocarcinoma, it also needs to provide choice and surgical methods prognostic evidence. on the implementation of hilar lesion en bloc resection, is still uncertain at this stage the most important treatment. A clinical classification and staging Clinical type commonly used method is the Bismuth Corlette classification [1]: bile duct confined to hepatic duct, left hepatic duct confluence is still smooth for the Department , bile duct invasion and involvement of the Ministry of convergence around the time of hepatic duct opening type, intrahepatic bile duct cancer has invaded one or two ducts type , a type which invaded the right hepatic duct for the bile duct, b-type invasion to bile duct and left hepatic duct, type is about a violation of common bile duct were . This classification reflects a good anatomic site of cancer for clinical provide an important basis for surgery. domestic scholars have found a source of intrahepatic bile ducts of hilar cholangiocarcin